Literature DB >> 15015644

Gene cloning of murine alpha-fetoprotein gene and construction of its eukaryotic expression vector and expression in CHO cells.

Jilin Yi1, Geng Tian.   

Abstract

To clone the murine alpha-fetoprotein (AFP) gene, construct the eukaryotic expression vector of AFP and express in CHO cells, total RNA were extracted from Hepa 1-6 cells, and then the murine alpha-fetoprotein gene was amplified by RT-PCR and cloned into the eukaryotic expression vector pcDNA3.1. The recombinant of vector was identified by restriction enzyme analysis and sequencing. After transient transfection of CHO cells with the vector, Western blotting was used to detect the expression of AFP. It is concluded that the 1.8 kb murine alpha-fetoprotein gene was successfully cloned and its eukaryotic expression vector was successfully constructed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15015644     DOI: 10.1007/BF02829426

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  27 in total

1.  DNA vaccines--designer vaccines for the 21st century.

Authors:  R A Seder; S Gurunathan
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

Review 2.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.

Authors:  W S Meng; L H Butterfield; A Ribas; V B Dissette; J B Heller; G A Miranda; J A Glaspy; W H McBride; J S Economou
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

4.  Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.

Authors:  C M Vollmer; F C Eilber; L H Butterfield; A Ribas; V B Dissette; A Koh; L D Montejo; M C Lee; K J Andrews; W H McBride; J A Glaspy; J S Economou
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

5.  Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.

Authors:  L H Butterfield; A Koh; W Meng; C M Vollmer; A Ribas; V Dissette; E Lee; J A Glaspy; W H McBride; J S Economou
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

Review 6.  Hepatocellular carcinoma.

Authors:  D F Schafer; M F Sorrell
Journal:  Lancet       Date:  1999-04-10       Impact factor: 79.321

7.  A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.

Authors:  R Xiang; F J Primus; J M Ruehlmann; A G Niethammer; S Silletti; H N Lode; C S Dolman; S D Gillies; R A Reisfeld
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

Review 8.  Antitumor vaccination: where we stand.

Authors:  M Bocchia; V Bronte; M P Colombo; A De Vincentiis; M Di Nicola; G Forni; L Lanata; R M Lemoli; M Massaia; D Rondelli; P Zanon; S Tura
Journal:  Haematologica       Date:  2000-11       Impact factor: 9.941

Review 9.  Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.

Authors:  P G Coulie; P Weynants; F Lehmann; J Herman; V Brichard; T Wölfel; A Van Pel; E De Plaen; F Brasseur; T Boon
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-08

10.  A carcinoembryonic antigen polynucleotide vaccine for human clinical use.

Authors:  R M Conry; A F LoBuglio; F Loechel; S E Moore; L A Sumerel; D L Barlow; J Pike; D T Curiel
Journal:  Cancer Gene Ther       Date:  1995-03       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.